Recurrent Fungemia Due to Candida auris

Emma M Griffith1, Christopher Marsalisi1, Jorge Verdecia2

  • 1Internal Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, USA.

Cureus
|July 18, 2024
PubMed

Insights

Recurrent multidrug-resistant Candida auris (C. auris) infections pose significant challenges. This case highlights the difficulties in managing invasive C. auris, emphasizing its resistance and high mortality risk.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Critical Care Medicine

Background:

  • Candida auris (C. auris) is an emerging multidrug-resistant fungal pathogen.
  • Invasive C. auris infections are associated with high morbidity and mortality.
  • Management of C. auris requires careful consideration of limited treatment options.

Observation:

  • A case of recurrent, multidrug-resistant C. auris fungemia is presented.
  • The patient experienced multiple hospitalizations and intensive care unit admissions over 12 months.
  • Septic and hypovolemic shock complicated the management of C. auris fungemia.

Findings:

  • Despite isolation and antifungal therapy, C. auris fungemia recurred.
  • The case underscores the challenges posed by multidrug-resistant C. auris.
  • Invasive C. auris infections demonstrate profound clinical implications.

Implications:

  • This case highlights the need for enhanced surveillance and infection control for C. auris.
  • Limited treatment options for multidrug-resistant C. auris contribute to poor outcomes.
  • Further research is needed to develop effective therapeutic strategies against C. auris.